MedPath

Probiotica Approach to Combat multi-resistent Enterocci: A Cross-over Clinical Trial on the Effect of Probiotics on Nosocomial Spread of CC17 Enterococcus faecium

Conditions
nosocomial
ARE
Enterococcus faecium
epidemiology
probioticsinfectie preventie
nosocomiaal
infection control
antimicrobial resistance
ARE, Enterococcus faecium, antibiotica resistentie, probiotica
Registration Number
NL-OMON25438
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
640
Inclusion Criteria

All admissions on two wards (gastroenterology/nephrology and geriatrics) of the University Medical Center Utrecht, where ARE colonization is endemic

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in acquisition rate of perianal ARE-colonization between the probiotic period and the control period
Secondary Outcome Measures
NameTimeMethod
Difference in prevalence of perianal ARE-colonization between the probiotic period and the control period
© Copyright 2025. All Rights Reserved by MedPath